On this page you can find further explanation on some key issues in the IOC Anti-Doping Rules, the Rules and Prohibited lists themselves together with all the other documentation relating to the Anti-Doping Rules for Beijing.

Please note, this is a guide produced by ISAF to assist the competitors and their team, however IT IS THE RESPONSIBILITY OF THE SAILOR TO ENSURE THEY COMPLY WITH ALL AREAS OF THE IOC ANTI-DOPING RULES FOR BEIJING 2008.

Anti-Doping Rules For Beijing 2008

The rules governing anti-doping at the Beijing Game are the International Olympic Committee Anti-Doping Rules applicable to the Games of the XXIX Olympiad, Beijing 2008. They are in force for the period of the Olympic Games, defined as “the period commencing on the date of the opening of the Olympic Village for the Olympic Games”, namely 27 July 2008, up until and including the day of the Closing Ceremony of the Olympic Games on 24 August 2008.

You can download the IOC Anti-Doping Rules for Beijing 2008 via the link below.

New Elements To The Anti-Doping Rules

Specific new elements of the rules include:         

• an athlete may be notified and tested more than once during the same day
• the fact that athletes who miss a test on two separate occasions during the Games, or on one occasion during the Games plus twice in the 18 months beforehand, will be considered to have committed an anti-doping rule violation
• possession of any substance from the list of prohibited substances will constitute a violation (previously only a selection from the prohibited list applied)    

Key Issues

The following are some key elements of the new Anti-Doping Rules identified by ISAF.

Beta-2 Agonists

Information for athletes going to the 2008 Olympic Sailing Competition and taking Beta-2 Agonists for ASTHMA or EXERCISE INDUCED ASTHMA (EIA) or EXERCISE-INDUCED BRONCHOCONSTRICTION (EIB).

Even if they have an Abbreviated Therapeutic Use Exemptions (ATUE) issued by ISAF or their National Anti-Doping Organization (NADO) all athletes taking Beta 2 Agonists – salbutamol, salmeterol, formoterol and terbutaline for example – must obtain approval for use during the Olympic Games from the IOC Medical Commission.

Athletes who request permission to inhale a Beta 2 Agonist during the 2008 Olympic Games will be required to submit test results to confirm that the athlete has objective evidence of asthma and/or EIA or EIB.

Applications must be addressed to the IOC Medical and Scientific Department using their on-line Therapeutic Use Exemption request form found on www.olympic.org/atue.

The doping control laboratory will report the presence in urine of any Beta 2 Agonist. For any athlete who has not received an authorisation from the IOC Medical Commission to inhale a Beta 2 Agonist(s), or who has not respected an approval granted to use any of these substances, the result of the doping control will be considered as an adverse analytical finding. The procedures in place for an adverse analytical finding will then be applied. For any questions related to the on-line form, please contact the IOC Medical and Scientific Department by email at beta2@olympic.org or by telephone on + 41 21 621 6111.

The IOC Guidelines for Beta 2 Agonist Use in Beijing can be downloaded via the link below.